IDH2 and acute myeloid leukemia: As IDH2 mutated AML often also has mutations in NPM1 and/or FLT3-ITD [2, 4], the cohort was separated into those with (n = 106, 41%) or without (n = 151, 59%) either of these two mutations reported at initial diagnosis.